BLFS BIOLIFE SOLUTIONS INC — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$29.19

Period return

+3.21 (+12.36%)

Volume

577.0K

2026-07-21O $28.61 H $29.43 L $28.54 C $29.19MA5 $29.37MA20 $28.13MA60 $25.31MA120 $23.12

6M · 124 barsYahoo Finance · USD2026-01-22 → 2026-07-21

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 08. 06.Highin 16 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2025. 12. 29.LowBUY7 months ago
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.
2025. 11. 24.LowBUY8 months ago
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.
2025. 08. 08.LowBUY12 months ago
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.
2025. 05. 13.LowBUYlast year
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.
2025. 03. 06.LowBUYlast year
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.
2025. 01. 08.LowBUY2 years ago
Northland Capital Markets: Outperform
US analyst rating / recommendation change.
2024. 12. 19.LowBUY2 years ago
Benchmark: Buy
US analyst rating / recommendation change.
2024. 12. 13.LowBUY2 years ago
Keybanc: Overweight
US analyst rating / recommendation change.
2024. 11. 18.LowBUY2 years ago
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $32.3 · 10 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Sector: Healthcare
Industry: Medical Instruments & Supplies
HQ: Bothell, WA, United States

BIOLIFE SOLUTIONS INC

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2025. 12. 29.	HC Wainwright & Co.	—	Maintain	Buy → Buy	—	HC Wainwright & Co.: Buy
2025. 11. 24.	HC Wainwright & Co.	—	Maintain	Buy → Buy	—	HC Wainwright & Co.: Buy
2025. 08. 08.	HC Wainwright & Co.	—	Maintain	Buy → Buy	—	HC Wainwright & Co.: Buy
2025. 05. 13.	HC Wainwright & Co.	—	Maintain	Buy → Buy	—	HC Wainwright & Co.: Buy
2025. 03. 06.	HC Wainwright & Co.	—	Maintain	Buy → Buy	—	HC Wainwright & Co.: Buy
2025. 01. 08.	Northland Capital Markets	—	Maintain	Outperform → Outperform	—	Northland Capital Markets: Outperform